These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3701389)

  • 1. Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
    Finkelstein DM; Ettinger DS; Ruckdeschel JC
    J Clin Oncol; 1986 May; 4(5):702-9. PubMed ID: 3701389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
    Ruckdeschel JC; Finkelstein DM; Ettinger DS; Creech RH; Mason BA; Joss RA; Vogl S
    J Clin Oncol; 1986 Jan; 4(1):14-22. PubMed ID: 3510278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.
    Bonomi PD; Finkelstein DM; Ruckdeschel JC; Blum RH; Green MD; Mason B; Hahn R; Tormey DC; Harris J; Comis R
    J Clin Oncol; 1989 Nov; 7(11):1602-13. PubMed ID: 2553879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin, and etoposide versus mitomycin and vinblastine (EST 2575, generation IV).
    Ruckdeschel JC; Day R; Weissman CH; Stolbach LL; Creech RH
    Cancer Treat Rep; 1984 Nov; 68(11):1325-9. PubMed ID: 6388831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patients.
    Shepard KV; Golomb HM; Bitran JD; Hoffman PC; Newman SB; DeMeester TR; Skosey C
    Cancer; 1985 Nov; 56(10):2385-90. PubMed ID: 3876149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy.
    Hoffman PC; Newman SB; Golomb HM; Demeester TR; Blough RR; Sovik CA
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):33-8. PubMed ID: 6303793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer.
    Niell HB; Griffin JP
    Med Pediatr Oncol; 1985; 13(6):341-5. PubMed ID: 3930930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of non-small cell bronchogenic carcinoma with vinblastine and mitomycin: a Southwest Oncology Group Study.
    Weick JK; Rainey JM; Livingston RB; Baker LH; O'Bryan RM; Chen TT
    Cancer Treat Rep; 1985 Jun; 69(6):583-5. PubMed ID: 2990709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer.
    Osoba D; Rusthoven JJ; Turnbull KA; Evans WK; Shepherd FA
    J Clin Oncol; 1985 Nov; 3(11):1478-85. PubMed ID: 2414409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer].
    Homma T; Yoneda S; Fukuda Y; Nakata M; Noguchi Y; Yoshida S
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2399-403. PubMed ID: 3015045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ftorafur, adriamycin and mitomycin C (FAM II) for extensive bronchogenic adenocarcinoma and large cell carcinoma.
    Salvati F; Cruciani AR; De Marinis A; Nunziati F; Portalone L
    Jpn J Clin Oncol; 1984 Mar; 14(1):3-6. PubMed ID: 6323790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study.
    Weick JK; Crowley J; Natale RB; Hom BL; Rivkin S; Coltman CA; Taylor SA; Livingston RB
    J Clin Oncol; 1991 Jul; 9(7):1157-62. PubMed ID: 1646292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study.
    Gregor A; Drings P; Burghouts J; Postmus PE; Morgan D; Sahmoud T; Kirkpatrick A; Dalesio O; Giaccone G
    J Clin Oncol; 1997 Aug; 15(8):2840-9. PubMed ID: 9256127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide.
    Jones AL; Holborn J; Ashley S; Smith IE
    Eur J Cancer; 1991; 27(7):866-70. PubMed ID: 1657078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy with mitomycin C, methotrexate, cisplatin, and vinblastine in the treatment of non-small cell lung cancer.
    Niell HB; Griffin JP; West WH; Neely CL
    Cancer; 1984 Oct; 54(7):1260-3. PubMed ID: 6088022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patients.
    Broder LE; Sridhar KS; Selawry OS; Charyulu KN; Rao RK; Saldana MJ; Lenz C
    Am J Clin Oncol; 1992 Dec; 15(6):480-6. PubMed ID: 1449109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.
    Joss RA; Alberto P; Obrecht JP; Barrelet L; Holdener EE; Siegenthaler P; Goldhirsch A; Mermillod B; Cavalli F
    Cancer Treat Rep; 1984 Sep; 68(9):1079-84. PubMed ID: 6090014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
    Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W
    Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
    Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
    Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.
    Ruckdeschel JC; Finkelstein DM; Mason BA; Creech RH
    J Clin Oncol; 1985 Jan; 3(1):72-9. PubMed ID: 3880810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.